부산대학교 도서관

Amaria, Rodabe N ; Prieto, Peter A ; Tetzlaff, Michael T ; Reuben, Alexandre ; Andrews, Miles C ; Ross, Merrick I ; Glitza, Isabella C ; Cormier, Janice ; Hwu, Wen-Jen ; Tawbi, Hussein A ; Patel, Sapna P ; Lee, Jeffrey E ; Gershenwald, Jeffrey E ; Spencer, Christine N ; Gopalakrishnan, Vancheswaran ; Bassett, Roland ; Simpson, Lauren ; Mouton, Rosalind ; Hudgens, Courtney W ; Zhao, Li ; Zhu, Haifeng ; Cooper, Zachary A ; Wani, Khalida ; Lazar, Alexander ; Hwu, Patrick ; Diab, Adi ; Wong, Michael K ; McQuade, Jennifer L ; Royal, Richard ; Lucci, Anthony ; Burton, Elizabeth M ; Reddy, Sangeetha ; Sharma, Padmanee ; Allison, James ; Futreal, Phillip A ; Woodman, Scott E ; Davies, Michael A ; Wargo, Jennifer A

In The Lancet Oncology February 2018 19(2):181-193

Pekala, Kelly R ; Ma, Xidi ; Kropp, Peter A ; Petersen, Christine P ; Hudgens, Courtney W ; Chung, Christine H ; Shi, Chanjuan ; Merchant, Nipun B ; Maitra, Anirban ; Means, Anna L ; Gannon, Maureen A

In Laboratory Investigation May 2014 94(5):517-527

Hallaert P; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, USA.; Roman JW; Department of Dermatology, Naval Medical Center Portsmouth (NMCP), Portsmouth, VA, USA.; Baker M; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, USA.; Hill NT; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, USA.; Marte JL; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Gulley JL; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Logemann N; Department of Dermatology, Walter Reed National Military Medical Center (WRNMMC), Bethesda, MD, USA.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Reuben A; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Brownell I; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, USA. isaac.brownell@nih.gov.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Guerrieri RA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fischer GM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Cortez JR; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Knighton BG; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ledesma DA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Delcid YF; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hu Q; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Onana CYB; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Carapeto FCL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tezlaff MT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; Huse JT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Burton EM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Glitza Oliva IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Davies MA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ferguson SD; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. SDFerguson@mdanderson.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Kumar S; UT MD Anderson Cancer Center, Houston, TX, USA. skumar11@mdanderson.org.; Pelster MS; Sarah Cannon Research Institute, Nashville, TN, USA.; Hasanov M; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Guerrieri RA; UT MD Anderson Cancer Center, Houston, TX, USA.; Hudgens CW; UT MD Anderson Cancer Center, Houston, TX, USA.; Ledesma DA; UT MD Anderson Cancer Center, Houston, TX, USA.; Wang F; UT MD Anderson Cancer Center, Houston, TX, USA.; Fischer GM; Brigham and Women's Hospital, Boston, MA, USA.; Simon JM; UT MD Anderson Cancer Center, Houston, TX, USA.; Haydu LE; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, FL, USA.; Katlowitz KV; UT MD Anderson Cancer Center, Houston, TX, USA.; Gopal YNV; UT MD Anderson Cancer Center, Houston, TX, USA.; McQuade JL; UT MD Anderson Cancer Center, Houston, TX, USA.; Kwong LN; UT MD Anderson Cancer Center, Houston, TX, USA.; Huse JT; UT MD Anderson Cancer Center, Houston, TX, USA.; Lazar AJ; UT MD Anderson Cancer Center, Houston, TX, USA.; Tetzlaff MT; University of California San Francisco, San Francisco, CA, USA.; Gershenwald JE; UT MD Anderson Cancer Center, Houston, TX, USA.; Joon AY; UT MD Anderson Cancer Center, Houston, TX, USA.; Chen K; UT MD Anderson Cancer Center, Houston, TX, USA.; Li Z; UT MD Anderson Cancer Center, Houston, TX, USA.; Ram PT; UT MD Anderson Cancer Center, Houston, TX, USA.; Ferguson SD; UT MD Anderson Cancer Center, Houston, TX, USA. sdferguson@mdanderson.org.; Davies MA; UT MD Anderson Cancer Center, Houston, TX, USA. mdavies@mdanderson.org.

Publisher: BioMed Central Country of Publication: England NLM ID: 101610673 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-5960 (Electronic) Linking ISSN: 20515960 NLM ISO Abbreviation: Acta Neuropathol Commun Subsets: MEDLINE

Guerrieri RA; Fischer GM; Kircher DA; Joon AY; Cortez JR; Grossman AH; Hudgens CW; Ledesma DA; Lazcano R; Onana CY; Knighton BG; Kumar S; Hu Q; Gopal YNV; McQuade JL; Deng W; Haydu LE; Gershenwald JE; Lazar AJ; Tetzlaff MT; Holmen SL; Davies MA

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Glitza Oliva IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. icglitza@mdanderson.org.; Ferguson SD; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bassett R Jr; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Foster AP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; John I; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hennegan TD; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rohlfs M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Richard J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iqbal M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dett T; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lacey C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jackson N; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodgers T; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Phillips S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Duncan S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Haydu L; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin R; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yee C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fischer GM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McCutcheon IE; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; O'Brien BJ; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tummala S; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Debnam M; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Guha-Thakurta N; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Carapeto FCL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Huse JT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tetzlaff MT; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; Burton EM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE

Spencer CN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; McCulloch JA; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Vetizou M; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Zhang X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wong MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Rodgers T; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Badger JH; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Helmink BA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Medicine, Monash University, Melbourne, VIC 3004, Australia.; Rodrigues RR; Frederick National Laboratory for Cancer Research, and Microbiome and Genetics Core, Laboratory of Integrative Cancer Immunology, CCR, NCI, NIH, Bethesda, MD 20852, USA.; Morgun A; Department of Pharmaceutical Science, Oregon State University, Corvallis, OR 97331, USA.; Kim YS; Nutritional Science Research Group, Division of Cancer Prevention, NCI, NIH, Rockville, MD 20850, USA.; Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hoffman KL; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.; Zheng J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Zhou Y; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Medik YB; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Kahn LM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson University of Texas Health Graduate School, Houston, TX 77030, USA.; Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Gaudreau PO; Canadian Cancer Trials Group and Department of Oncology, Queen's University, Kingston, ON K7L 3N6, Canada.; Harris AL; Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Jamal MA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Baruch EN; Department of Internal Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA.; Perez-Guijarro E; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA.; Day CP; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA.; Merlino G; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA.; Pazdrak B; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Lochmann BS; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Szczepaniak-Sloane RA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Anderson J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Zobniw CM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Posada E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Sirmans E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Simon J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Clise-Dwyer K; Advanced Cytometry and Sorting Facility at South Campus, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Schneider S; Advanced Cytometry and Sorting Facility at South Campus, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Chapman T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Anang NAS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Duncan S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Toker J; Department of Neurosurgery, Harvard University, Cambridge, MA 02138, USA.; Department of Oncology, University of Cambridge, Cambridge CB2 1TN, UK.; Malke JC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Woodman SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Jensen V; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Samuels Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel.; Straussman R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel.; Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Nezi L; Dipartimento di Oncologia Sperimentale, Instituto Europeo di Oncologia, Milan, P.I. 08691440153, Italy.; Petrosino JF; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Lazar AJ; MD Anderson University of Texas Health Graduate School, Houston, TX 77030, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hu J; Department of Biostatistics, Columbia University, New York, NY 10032, USA.; Jenq RR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Stem Cell Transplant, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Tetzlaff MT; Departments of Pathology and Dermatology, Dermatopathology and Oral Pathology Unit, University of California San Francisco, San Francisco, CA 94115, USA.; Yan Y; Department of Biostatistics and the Harvard T.H. Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Garrett WS; Department of Molecular Metabolism, T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Huttenhower C; Department of Biostatistics and the Harvard T.H. Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.; Sharma P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Watowich SS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Cohen L; Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Trinchieri G; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Daniel CR; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Tetzlaff, Michael T; Singh, Rajesh R; Seviour, Elena G; Curry, Jonathan L; Hudgens, Courtney W; Bell, Diana; Wimmer, Daniel A; Ning, Jing; Czerniak, Bogdan A; Zhang, Li; Davies, Michael A; Prieto, Victor G; Broaddus, Russell R; Ram, Prahlad; Luthra, Rajyalakshmi; Esmaeli, Bita

Journal of Pathology; Sep2016, Vol. 240 Issue 1, p84-95, 12p

Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Navarrete J; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Ledesma DA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Lazcano RN; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Alani A; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Huen A; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Duvic M; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Nagarajan P; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Aung PP; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Curry JL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Miranda RN; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Torres-Cabala CA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

Mitra A; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Quantitative Sciences Graduate Training Program, Graduate School of Biomedical Sciences, Houston, Texas, USA.; Andrews MC; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia.; Roh W; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; De Macedo MP; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hudgens CW; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Carapeto F; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Singh S; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Reuben A; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Wang F; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Mao X; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Song X; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Wani K; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Tippen S; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ng KS; Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Schalck A; Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Sakellariou-Thompson DA; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Chen E; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Reddy SM; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Wiesnoski D; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Little LD; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Gumbs C; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Cooper ZA; AstraZeneca, Gaithersburg, Maryland, USA.; Burton EM; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hwu P; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Davies MA; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Zhang J; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Bernatchez C; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Navin N; Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Sharma P; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Allison JP; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Wargo JA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Yee C; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Tetzlaff MT; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hwu WJ; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Lazar AJ; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Futreal PA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. AFutreal@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Glitza Oliva IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. icglitza@mdanderson.org.; Ferguson SD; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bassett R Jr; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Foster AP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; John I; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hennegan TD; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rohlfs M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Richard J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iqbal M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dett T; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lacey C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jackson N; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodgers T; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Phillips S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Duncan S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Haydu L; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin R; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yee C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fischer GM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McCutcheon IE; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; O'Brien BJ; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tummala S; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Debnam M; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Guha-Thakurta N; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Carapeto FCL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Huse JT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tetzlaff MT; Department of Pathology, The University of California San Francisco, San Francisco, CA, USA.; Burton EM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Zhou Y; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Medik YB; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Patel B; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Zamler DB; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Chen S; Ministry of Education Key Lab of Bioinformatics and Bioinformatics Division, Beijing National Research Center for Information Science and Technology; Department of Automation, Tsinghua University, Beijing, China.; Chapman T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Schneider S; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Park EM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Babcock RL; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Chrisikos TT; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Kahn LM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Dyevoich AM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Pineda JE; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Wong MC; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX.; Mishra AK; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX.; Cass SH; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Cogdill AP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Johnson DH; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Johnson SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Ledesma DA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wang J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wadud Khan MA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Peterson CB; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Joon AY; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Peng W; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Li HS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Tang X; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Raso MG; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Zhang X; Ministry of Education Key Lab of Bioinformatics and Bioinformatics Division, Beijing National Research Center for Information Science and Technology; Department of Automation, Tsinghua University, Beijing, China.; Foo WC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Tetzlaff MT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Diehl GE; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Clise-Dwyer K; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Whitley EM; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.; Gubin MM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Hwu P; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wargo JA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Watowich SS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX.

Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE

Hahn AW; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Menk AV; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.; Rivadeneira DB; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.; Augustin RC; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.; Xu M; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Li J; Department of Bioinformatics and Computational Biology, Division of Basic Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas.; Wu X; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Mishra AK; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Gide TN; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.; Quek C; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.; Zang Y; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.; Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Menzies AM; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.; Daniel CR; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas.; Hudgens CW; Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Nowicki T; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, California.; Haydu LE; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.; Khan MAW; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.; Gopalakrishnan V; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.; Burton EM; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Malke J; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.; Simon JM; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.; Bernatchez C; Department of Biologics Development, Division of Therapeutics Discovery, University of Texas MD Anderson Cancer Center, Houston, Texas.; Putluri N; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.; Woodman SE; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Vashisht Gopal YN; Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Guerrieri R; Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Fischer GM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Wang J; Department of Biostatistics, Division of Biosciences, University of Texas MD Anderson Cancer Center, Houston, Texas.; Wani KM; Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Thompson JF; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.; Lee JE; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.; Hwu P; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa Bay, Florida.; Ajami N; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Gershenwald JE; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, California.; Long GV; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Scolyer RA; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Tetzlaff MT; Division of Dermatopathology, Department of Pathology, University of California San Francisco, San Francisco, California.; Lazar AJ; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Schadendorf D; Department of Dermatology, Venereology, and Allergology, University Hospital Essen and German Cancer Consortium, Partner site Essen, Germany.; Wargo JA; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.; Kirkwood JM; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.; DeBerardinis RJ; Children's Medical Research Institute and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas.; Liang H; Department of Bioinformatics and Computational Biology, Division of Basic Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas.; Futreal A; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Zhang J; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Wilmott JS; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.; Peng W; Department of Biology and Biochemistry, University of Houston, Houston, Texas.; Davies MA; Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.; Delgoffe GM; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.; Najjar YG; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.; McQuade JL; Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Vellano CP; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Chelvanambi M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Witt RG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Daniele JR; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Titus M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Conforti F; Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.; Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lastrapes MJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ologun G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Guthrie Courtland Medical Center, Courtland, NY, USA.; Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Immunai, New York, NY, USA.; Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Prieto P; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, University of Rochester, Rochester, NY, USA.; Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Helmink B; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Washington University in St Louis, St Louis, MO, USA.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kovacs JJ; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Woodman SE; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Moffitt Cancer Center, Tampa, FL, USA.; Peoples M; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cooper ZA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; AstraZeneca, Gaithersburg, MD, USA.; Zhu H; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gao G; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Banerjee H; Clinical Development and Analytics, Novartis Pharmaceuticals, East Hanover, NJ, USA.; Lau M; Novartis Pharma, Basel, Switzerland.; Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lucci A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pala L; Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.; Pagan E; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.; Segura RL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu Q; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Borthwick MS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lau E; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Yates MS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, University of California, San Francisco, CA, USA.; Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mahendra M; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ma X; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Logothetis C; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kulstad Z; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng N; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Federico L; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Long GV; Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arur S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Moran AE; Cell, Development & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Heffernan TP; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. TPHeffernan@mdanderson.org.; Marszalek JR; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; PubMed not MEDLINE

Kandl TJ; Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Sagiv O; Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Curry JL; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ning J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ma J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hudgens CW; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Van Arnam J; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Esmaeli B; Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Tetzlaff MT; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE

Vellano CP; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Chelvanambi M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Witt RG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Daniele JR; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Titus M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Conforti F; Division of Melanoma, Sarcomas, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.; Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lastrapes MJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ologun G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Guthrie Courtland Medical Center, Courtland, NY, USA.; Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Immunai, New York, NY, USA.; Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Prieto P; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, University of Rochester, Rochester, NY, USA.; Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Helmink B; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Washington University in St Louis, St Louis, MO, USA.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kovacs JJ; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Woodman SE; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Moffitt Cancer Center, Tampa, FL, USA.; Peoples M; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cooper ZA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; AstraZeneca, Gaithersburg, MD, USA.; Zhu H; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gao G; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Banerjee H; Clinical Development and Analytics, Novartis Pharmaceuticals, East Hanover, NJ, USA.; Lau M; Novartis Pharma, Basel, Switzerland.; Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lucci A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pala L; Division of Melanoma, Sarcomas, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.; Pagan E; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.; Segura RL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu Q; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Borthwick MS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lau E; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Yates MS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, University of California, San Francisco, CA, USA.; Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mahendra M; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ma X; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Logothetis C; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kulstad Z; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng N; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Federico L; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Long GV; Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arur S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Moran AE; Cell, Development & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Heffernan TP; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. TPHeffernan@mdanderson.org.; Marszalek JR; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Wu C; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Peng S; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.; Pilié PG; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Geng C; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Park S; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Manyam GC; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lu Y; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Yang G; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tang Z; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kondraganti S; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wang D; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ledesma DA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Torres-Cabala CA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Curry JL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Troncoso P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Corn PG; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Broom BM; Bioinformatics and Computational Biology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Thompson TC; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas. timthomp@mdanderson.org.

Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.; Deparment of Medicine, Monash University, Melbourne, Victoria, Australia.; Duong CPM; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.; Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iebba V; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Chen WS; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Dermatology, University of South Florida Morsani College of Medicine, Tampa, FL, USA.; Derosa L; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.; Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cogdill AP; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wong MC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ferrere G; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.; Fluckiger A; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.; Roberti MP; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.; Opolon P; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Alou MT; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.; Yonekura S; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.; Roh W; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Spencer CN; Department of Informatics, Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Curbelo IF; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Vence L; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Reuben A; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lastrapes M; MD Anderson Cancer Center University of Texas Health Graduate School of Biomedical Sciences (GSBS), Houston, TX, USA.; Baruch EN; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cooper ZA; AstraZeneca, Gaithersburg, MD, USA.; Prieto PA; Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA.; Wani K; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lazar AJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hudgens CW; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Callahan MK; Department of Informatics, Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Adamow M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Division of Immunology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Postow MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Division of Immunology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Ariyan CE; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Gaudreau PO; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nezi L; Istituto Europeo di Oncologia, Milan, Italy.; Raoult D; Aix-Marseille Université, MEPHI, IRD, IHU Méditerranée Infection, Marseille, France.; Mihalcioiu C; Department of Medicine, Faculty of Medicine and Health Sciences, McGill University Health Centre, Montreal, Quebec, Canada.; Elkrief A; Cedars Cancer Center, McGill University Health Centre, Montreal, Quebec, Canada.; Pezo RC; Division of Medical Oncology, University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada.; Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Simon JM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McQuade J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hwu WJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Woodman SE; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Watowich S; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhao L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Petrosino J; Department of Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.; Jenq RR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sharma P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Routy B; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.; Zitvogel L; Gustave Roussy Cancer Campus (GRCC), Villejuif, France. laurence.zitvogel@gustaveroussy.fr.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France. laurence.zitvogel@gustaveroussy.fr.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France. laurence.zitvogel@gustaveroussy.fr.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Haymaker C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Johnson DH; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Murthy R; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bentebibel SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Uemura MI; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Safa H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; James M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Andtbacka RHI; Surgical Oncology Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Johnson DB; Division of Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Shaheen M; Department of Medicine and Cancer Center, University of Arizona, Tucson, Arizona.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Rahimian S; Idera Pharmaceuticals, Inc., Exton, Pennsylvania.; Chunduru SK; Idera Pharmaceuticals, Inc., Exton, Pennsylvania.; Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tetzlaff MT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Overwijk WW; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Gabrail N; Department of Oncology, Gabrail Cancer Center, Canton, Ohio.; Agrawal S; Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.; Doolittle G; Department of Oncology, University of Kansas Medical Center, Kansas City, Kansas.; Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Markowitz J; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. adiab@mdanderson.org cbernatchez@mdanderson.org.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. adiab@mdanderson.org cbernatchez@mdanderson.org.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE